Businesses thinking about product innovation typically dive deep into performance considerations: how can a better feature, easier experience, or faster step be achieved?
What does it take to bring a new product to market? Read how T&Co was able to help a food start up with its commercialization strategy.
Why is it still so difficult for many organizations to raise prices in today’s inflationary environment? Pricing changes require four critical elements.
T&Co has worked closely with dozens of market leading organizations on an issue remains elusive for many management teams – delivering profitable, above-market organic revenue growth. Based on a T&Co analysis of over 500 growth initiatives, we found that the actual impact of any individual growth initiative varies dramatically from the expected result.
Despite the fanfare, clinical approval by the FDA is only the start of the go-to-market journey for medical devices or pharmaceuticals. To actually achieve usage by real patients and providers, medtech companies must navigate a complex network of medical codes, commercial insurance plans, government funded plans, provider questions and reimbursement rates.
It turns out that executives of even the most established companies can draw important lessons from startups to better navigate the increasingly changing and competitive business environment we live in today.
We’ve identified 3 start-up principles that can help any corporation better tackle innovation and growth.
Treacy & Company’s proven growth diagnostic tools and methodologies – Market Mapping, Sources of Revenue Analysis, Main Parameters of Value (MPV) Analysis, Organizational Growth Discipline Assessment – offer our private equity clients a valuable complement to their traditional commercial due diligence asks.